Earkart Limited IPO Details
SME
Earkart IPO opens for subscription on 25 Sep 2025 and closes on 29 Sep 2025. The IPO will be listed on BSE with the tentative listing date set for 03 Oct 2025.
Earkart IPO price band has been fixed at ₹135 – ₹135 per share.The face value is ₹10 per share with a lot size of 1000.
Earkart IPO total issue size comprises 36,49,000 shares (aggregating up to ₹49.26 Cr.). This includes a fresh issue of 33,15,000 shares (aggregating up to ₹44.75 Cr.). Offer for Sale consists of 3,34,000 shares (aggregating up to ₹4.51 Cr.). Pre-issue shareholding stands at 1,04,38,932, which will increase to 1,37,53,932 post-issue.
Earkart IPO Lot Size : Individual Minimum is 2 lots (2,000 shares) amounting to ₹270,000. Individual Maximum is 2 lots (2,000 shares) amounting to ₹270,000. HNI Minimum is 3 lots (3,000 shares) amounting to ₹405,000.
The Lead Managers for Earkart IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Sarthi Capital Advisors Private Limited. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Rikhav Securities. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Earkart Limited RHP.
Earkart IPO Details
Earkart IPO Subscription
Earkart IPO Application Wise Breakup
Earkart IPO Dates
- 25 Sep 2025Opening dateOPD
- 29 Sep 2025Closing dateCOD
- 30 Sep 2025Allotment Date BOA
- 01 Oct 2025Initiation of RefundsIOR
- 01 Oct 2025Credit of SharesCOS
- 03 Oct 2025Listing dateLID
Earkart IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2000 | ₹270,000 |
| Individual Maximum | 2 | 2000 | ₹270,000 |
| HNI Minimum | 3 | 3000 | ₹405,000 |
Earkart IPO Reservation
Promoter Holding
Documents
Earkart IPO Valuations
Earkart Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 30.29 | 19.25 | 14.73 |
| Total Income | 43.19 | 31.97 | 28.97 |
| Profit After Tax | 6.88 | 3.06 | 1.31 |
| EBITDA | 9.76 | 3.55 | 1.61 |
| NET Worth | 19.92 | 13.03 | 6.56 |
| Reserves and Surplus | 9.48 | 12.97 | 6.49 |
| Total Borrowing | 4.96 | 4.00 | 1.21 |
| Amount in ₹ Crore | |||
About Earkart IPO
Earkart Limited is a HealthTech platform, specializing in hearing aids and related accessories. It offers modern hearing devices, like Receiver-In-Canal (RIC), Invisible (IIC), Behind-The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC) and Completely-In-Canal (CIC).
It also offers and distributes other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) for physically challenged.
The company sells products through a network of partners and clinics, both domestically and globally. It is also a trusted Government e-Market (GeM) supplier of hearing aids to ALIMCO under Ministry of Social Justice and Empowerment.
In April 2024, the company has launched Shop in Shop (SIS) model, wherein it offers franchise to opticians and ENT/optical clinics. As on date, the company operates 49 SIS clinics across 22 cities in 6 states and 2 Union Territories, i.e., Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh.
Its manufacturing facility is located in Noida, across 4,500 square feet
Strength Of Earkart IPO
1. We have diversified client base ranging from government, to, clinics, retailers and doctors.
2. Established and proven track record.
3. Leveraging the experience of our Promoter.
4. Experienced management team and a motivated Employees.
5. Cordial relations with our client.
Risk Of Earkart IPO
1. Our revenue from sale of products derived from government institutions accounted for 69.32%, 75.85% and 86.56% for the Fiscal 2025, Fiscal 2024 and Fiscal 2023 respectively. A failure to secure similar government contracts or orders in the future could adversely impact our business, operating results, and financial condition.
2. We are subject to complex laws and governmental regulations governing our products and our business operations, compliance with these laws and regulations requires time and cost, and any adverse regulatory action may adversely affect our financial condition, cash flows and business operations.
3. We face risks relating to sourcing of raw materials and components for manufacturing of our hearing aids and related devices from third parties.
4. Our Manufacturing Facility is located in Noida, Uttar Pradesh. Any disruption, breakdown or shutdown of our Manufacturing may have a material adverse effect on our business, financial condition, results of operations and cash flow.
5. Loss of any of our key customers or reduction in demand from our customers may materially and adversely affect our business and financial performance.
6. Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, and could have an adverse effect on our business, results of operations, financial condition and cash flows.
7. We are dependent on the success of our remote audiometry system Earkart OMNI and our research and development activities and the failure to develop new or improved products or process improvements or production techniques could adversely affect our business, financial condition, cash flows and results of operations and have a negative impact on our competitive position.
8. If we cannot protect our intellectual property our ability to sell current or future products may be negatively impacted.
9. We have had negative cash flows in the past and it is possible that we may experience negative cash flows in the future.
10. The restated financial statements have been provided by peer reviewed chartered accountants who is not statutory auditor of our Company.
Objectives Earkart IPO
1. Funding incremental working capital requirements of our Company
2. Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities
3. General Corporate Purposes
Company Contact Details
Earkart Ltd.
Shop No. 8-P, Street No. 6,
Vasundhara Enclave,
East Delhi, New Delhi, 110096
Phone: 0120-4102857
Email: cs@earkart.in
Website: https://www.earkart.in/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
Market Maker Reports